Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

First study to test osilodrostat in children and adolescents with Cushing's disease

May 31, 2019

Mereo reports 6-month open-label data from phase IIb study of BPS-804 in osteogenesis imperfecta

May 30, 2019

Amicus and University of Pennsylvania expand gene therapy collaboration

May 30, 2019

TLRs in DIO

May 29, 2019

Zealand Pharma describes amylin and/or calcitonin receptor agonists

May 27, 2019

Beta Bionics and Zealand initiate home-use trial of the iLet bionic pancreas with dasiglucagon

May 23, 2019

New compounds for obesity presented by Ube Industries

May 23, 2019

The Medicines Company reports long-term data on effects of inclisiran sodium on LDL-C

May 23, 2019

JCR initiates phase I trial of long-acting growth hormone JR-142

May 22, 2019

FDA clears Abeona's IND for phase I/II study of gene therapy ABO-202 for CLN1 disease

May 22, 2019

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...